Data as of Sep 23
| -0.05 / -0.20%|
ABIOMED, Inc. develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. The company provides medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. It develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and performing the pumping function of the heart. The company's products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery. ABIOMED was founded in 1981 and is headquartered in Danvers, MA.
|Michael R. Minogue||Chairman, President & Chief Executive Officer|
|David M. Weber||Chief Operating Officer|
|Robert L. Bowen||Chief Financial Officer, Treasurer, CAO & VP|
|Karim Benali||Chief Medical Officer|
|Thorsten Siess||Chief Technology Officer|